Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32).
about
Establishment of induced pluripotent stem cells from normal B cells and inducing AID expression in their differentiation into hematopoietic progenitor cells.Paradoxical expression of INK4c in proliferative multiple myeloma tumors: bi-allelic deletion vs increased expression.Alterations of Fas and Fas-related molecules in patients with silicosis.Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide.Discovery and Optimization of Macrocyclic Quinoxaline-pyrrolo-dihydropiperidinones as Potent Pim-1/2 Kinase Inhibitors.Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells.Hypoxia reduces CD138 expression and induces an immature and stem cell-like transcriptional program in myeloma cells.PDK1 inhibition is a novel therapeutic target in multiple myelomaLactate, a putative survival factor for myeloma cells, is incorporated by myeloma cells through monocarboxylate transporters 1.Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cells.Detection, epitope-mapping and function of anti-Fas autoantibody in patients with silicosis.Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival.Lactate dehydrogenase production and release in a newly established human myeloma cell line.Human bone marrow stroma-dependent cell line MOLP-5 derived from a patient in leukaemic phase of multiple myeloma.A new multiple myeloma cell line, MEF-1, possesses cyclin D1 overexpression and the p53 mutation.Human myeloma cell apoptosis induced by interferon-alpha.Fas/Apo-1 (CD95)-mediated and CD95-independent apoptosis of malignant plasma cells.Monoclonal antibody against PRAD1/cyclin D1 stains nuclei of tumor cells with translocation or amplification at BCL-1 locus.A novel selective small-molecule PI3K inhibitor is effective against human multiple myeloma in vitro and in vivo.A case of salivary-type amylase-producing multiple myeloma presenting as mediastinal plasmacytoma and myelomatous pleural effusion.Expression and in vitro modification of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP-receptor in human myeloma cells.Bufalin induces DNA damage response under hypoxic condition in myeloma cells.Establishment of CD7+ human myeloma sister cell lines, KMS-21-PE and KMS-21-BM, carrying t(11;14) and t(8;14).Pseudocyst or tumour? An amylase-producing leiomyosarcoma.IgG-kappa-type plasmacytoma secreting salivary-type amylase in adult T-cell leukemia.
P2860
Q33687796-E6CB0823-0A9D-480D-8B77-2A5E28C890EEQ35126641-8065EF86-F976-4184-B687-2AF4536487F2Q36459053-EB01BB7C-BFDC-479F-A5CE-C2573A88664DQ36640589-30FBFD55-B2BF-4C41-8D17-B18D97FCCE5EQ36806772-7B10C037-FAF9-4FFE-A660-3A2332E8095DQ38926469-450C3357-67C1-4AA2-A0CC-279FFA8504AEQ39078376-7DDE7716-0305-4B57-84D7-37EBAB3442E1Q39210001-EEA2AB1F-EB3B-41EA-BF59-DC0992196CB7Q39896435-34FDB620-8C4D-4B8E-A905-2CD0D4FF0A8BQ40333400-21A1A503-C9E3-4769-AE57-5E657B7F71CBQ40383852-8DEE32CA-737E-4670-B2F6-72EC51D82A6EQ40420617-DE12E439-B157-48B2-8C70-1EFC69AE4BABQ40815911-511D9A17-E0D0-4AF1-B1D6-F5034B2E02A7Q40874983-93B5AD65-1329-43F3-9CFD-6F6ECCAB79E1Q40957310-4BDFC63E-09FB-44EF-A862-220C8D5B3AE1Q40992802-E87C9CC1-8EEB-4260-A166-1CD4681D5702Q41363115-6D1483E0-6F65-42A8-87F0-1149806EB975Q41444722-760B5C3C-51C2-4F51-A8B0-2F4EDFD596A1Q42959293-B7C45BF3-C5A3-4E6D-88BB-45809F1A3A38Q42969990-B4633E04-9F88-4940-9279-7CC5CEFDAA9BQ43621671-CC165C90-8F80-4F26-9CE8-824367D88BE0Q52721814-064084E2-98F8-4B26-96F3-536BD79A341DQ52832416-9870D09D-2B86-4857-A24D-33689885D6BAQ55088726-2C3119F3-194C-44B3-89BC-3D7A86D1CC7BQ55241322-C1C89704-01EF-4734-8B36-DE37C4D2929E
P2860
Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32).
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Two human myeloma cell lines, ...... ome marker, t(11;14)(q13;q32).
@en
Two human myeloma cell lines, ...... ome marker, t(11;14)(q13;q32).
@nl
type
label
Two human myeloma cell lines, ...... ome marker, t(11;14)(q13;q32).
@en
Two human myeloma cell lines, ...... ome marker, t(11;14)(q13;q32).
@nl
prefLabel
Two human myeloma cell lines, ...... ome marker, t(11;14)(q13;q32).
@en
Two human myeloma cell lines, ...... ome marker, t(11;14)(q13;q32).
@nl
P2093
P2860
P1476
Two human myeloma cell lines, ...... ome marker, t(11;14)(q13;q32).
@en
P2093
P2860
P304
P356
10.1111/J.1365-2141.1989.TB00252.X
P407
P577
1989-10-01T00:00:00Z